Advertisement

Hormones

, Volume 16, Issue 4, pp 429–439 | Cite as

Sarcopenia: From definition to treatment

  • Yannis Dionyssiotis
  • Athina Kapsokoulou
  • Eleni Samlidi
  • Antonios G. Angoules
  • Jannis Papathanasiou
  • Efstathios Chronopoulos
  • Ifigenia Kostoglou-Athanassiou
  • Georgios Trovas
Commentary
  • 39 Downloads

Key words

DXA Drugs Nutrition Physical activity Rehabilitation Sarcopenia 

References

  1. 1.
    Rodriguez-Mañas L, Rodríguez-Artalejo F, Sinclair AJ, 2017 The Third Transition: The Clinical Evolution Oriented to the Contemporary Older Patient. J Am Med Dir Assoc 18: 8–9.CrossRefGoogle Scholar
  2. 2.
    Brink W, 2007 Preventing Sarcopenia. LifeExtension Magazine.Google Scholar
  3. 3.
    Anker SD, Morley JE, von Haehling S, 2016 Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 7: 512–514.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Working Group on Functional Outcome Measures for Clinical Trials, Bhasin S, Espeland MA, Evans WJ, et al, 2009 Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators. J Gerontol A Biol Sci Med Sci 64: 487–491.CrossRefGoogle Scholar
  5. 5.
    Rosenberg I, 1989 Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 50: 1231–1233.CrossRefGoogle Scholar
  6. 6.
    Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E, 2003 Sarcopenia in elderly men and women — the Rancho Bernardo study. Am J Prev Med 25: 226–231.CrossRefGoogle Scholar
  7. 7.
    Mithal A, Bonjour JP, Boonen S, et al, 2013 IOF CSA Nutrition Working Group. Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int 24: 1555–1566.CrossRefGoogle Scholar
  8. 8.
    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al, European Working Group on Sarcopenia in Older People 2010, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412–423.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Janssen I, Heymsfield SB, Ross R, 2002 Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50: 889–896.CrossRefGoogle Scholar
  10. 10.
    Yaxley A, Miller MD, Fraser RJ, Cobiac L, Crotty M, 2012 The complexity of treating wasting in ambulatory rehabilitation: Is it starvation, sarcopenia, cachexia or a combination of these conditions? Asia Pac J Clin Nutr 21: 386–393.PubMedGoogle Scholar
  11. 11.
    Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R, 2004 The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52: 80–85.CrossRefGoogle Scholar
  12. 12.
    Baumgartner RN, Koehler KM, Gallagher D, et al, 1998 Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755–763.CrossRefGoogle Scholar
  13. 13.
    Cruz-Jentoft AJ, Landi F, Schneider SM, et al, 2014 Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43: 748–759.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Fielding RA, Vellas B, Evans WJ, et al, 2011 Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12: 249–256.CrossRefGoogle Scholar
  15. 15.
    Joseph C, Kenny AM, Taxel P, Lorenzo JA, Duque G, Kuchel GA, 2005 Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol Aspects Med 26: 181–201.CrossRefGoogle Scholar
  16. 16.
    Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB, 2010 Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21: 543–559.CrossRefGoogle Scholar
  17. 17.
    Zisman A, Peroni OD, Abel ED, et al, 2000 Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6: 924–928.CrossRefGoogle Scholar
  18. 18.
    Hedman A, Berglund L, Essén-Gustavsson B, Reneland R, Lithell H, 2000 Relationships between muscle morphology and insulin sensitivity are improved after adjustment for intra-individual variability in 70-year-old men. Acta Physiol Scand 169: 125–132.CrossRefGoogle Scholar
  19. 19.
    Johnston DE, 1985 Tendons, skeletal muscles, and ligaments in health and disease. In: Newton CD, Nunamaker DM, Textbook of small animal orthopaedics. Philadelphia: Lippincott, pp: 65–76.Google Scholar
  20. 20.
    Patel HP, Clift E, Lewis L, Cooper C, 2017 Epidemiology of sarcopenia and frailty, frailty and sarcopenia — Onset, development and clinical challenges, Yannis Dionyssiotis (Ed.), InTech, DOI: 10.5772/intechopen.69771. Available from: https://doi.org/www.intechopen.com/books/frailty-and-sarcopenia-onset-development-and-clinicalchallenges/epidemiology-of-sarcopenia-and-frailty
  21. 21.
    Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D, 2002 Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 76: 378–383.CrossRefGoogle Scholar
  22. 22.
    Clark BC, Manini TM, 2008 Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci 63: 829–834.CrossRefGoogle Scholar
  23. 23.
    Peeters GM, de Vries OJ, Elders PJ, Pluijm SM, Bouter LM, Lips P, 2007 Prevention of fall incidents in patients with a high risk of falling: design of a randomised controlled trial with an economic evaluation of the effect of multidisciplinary transmural care. BMC Geriatr 7: 15.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Runge M, Schacht E, 2005 Multifactorial pathogenesis of falls as a basis for multifactorial interventions. J Musculoskelet Neuronal Interact 5: 127–134.PubMedGoogle Scholar
  25. 25.
    Lauretani F, Russo CR, Bandinelli S, et al, 2003 Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985) 95: 1851–1860.CrossRefGoogle Scholar
  26. 26.
    Ilie AC, Pislaru AI, Macsim IC, 2017 Sarcopenia and the importance of biochemical determinations in the hospitalised older adults. E-Health and Bioengineering Conference (EHB), Sinaia, pp; 281–284.Google Scholar
  27. 27.
    Volpi E, Nazemi R, Fujita S, 2004 Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care 7: 405–410.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Dionyssiotis Y, Chhetri JK, Piotrowicz K, Gueye T, Sánchez E, 2017 Impact of nutrition for rehabilitation of older patients: report on the 1st EICA-ESPRM-EUGMS train the trainers course. Eur Geriatr Med 8: 183–190.CrossRefGoogle Scholar
  29. 29.
    Waters DL, Baumgartner RN, Garry PJ, 2000 Sarcopenia: current perspectives. The Journal of Nutrition Health and Aging 4: 133–139.Google Scholar
  30. 30.
    Houston DK, Nicklas BJ, Ding J, et al, 2008 Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr January 87: 150–155.CrossRefGoogle Scholar
  31. 31.
    Campbell WW, Crim MC, Dallal GE, Young VR, Evans WJ, 1994 Increased protein requirements in elderly people: new data and retrospective reassessment. Am J Clin Nutr 60: 501–509.CrossRefGoogle Scholar
  32. 32.
    Campbell WW, Evans WJ, 1996 Protein requirements of elderly people. Eur J Clin Nutr 50: Suppl 1: 180–185.Google Scholar
  33. 33.
    Brose A, Parise G, Tarnopolsky MA, 2003 Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci 58: 11–19.CrossRefGoogle Scholar
  34. 34.
    Chrusch MJ, Chilibeck PD, Chad KE, Davison KS, Burke DG, 2001 Creatine supplementation combined with resistance training in older men. Med Sci Sports Exerc 33: 2111–2117.CrossRefGoogle Scholar
  35. 35.
    Valenzuela RE, Ponce JA, Morales-Figueroa GG, Muro KA, Carreón VR, Alemán-Mateo H, 2013 Insufficient amounts and inadequate distribution of dietary protein intake in apparently healthy older adults in a developing country: implications for dietary strategies to prevent sarcopenia. Clin Interv Aging 8: 1443–1148.Google Scholar
  36. 36.
    Roth SM, Ferrel RE, Hurley BF, 2000 Strength Training for the Prevention and Treatment of Sarcopenia. J Nutr Health Aging 4: 143–155.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Hasten DL, Pak-Loduca J, Obert KA, Yarasheski KE, 2000 Resistance exercise acutely increases MHC and mixed muscle protein synthesis rates in 78–84 and 23–32 yr olds. Am J Physiol Endocrinol Metab 278: E620–626.CrossRefGoogle Scholar
  38. 38.
    Buehring B, Binkley N, 2013 Myostatin—the holy grail for muscle, bone, and fat? Curr Osteoporos Rep 11: 407–414.CrossRefGoogle Scholar
  39. 39.
    Elliott B, Renshaw D, Getting S, Mackenzie R, 2012 The central role of myostatin in skeletal muscle and whole body homeostasis. Acta Physiol (Oxf) 205: 324–340.CrossRefGoogle Scholar
  40. 40.
    Attie KM, Borgstein NG, Yang Y, et al, 2013 A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve 47: 416–423.CrossRefGoogle Scholar
  41. 41.
    Meriggioli MN, Roubenoff R, 2015 Prospect for pharmacological therapies to treat skeletal muscle dysfunction. Calcif Tissue Int 96: 234–242.CrossRefGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2017

Authors and Affiliations

  • Yannis Dionyssiotis
    • 1
  • Athina Kapsokoulou
    • 2
  • Eleni Samlidi
    • 3
  • Antonios G. Angoules
    • 4
  • Jannis Papathanasiou
    • 5
  • Efstathios Chronopoulos
    • 6
  • Ifigenia Kostoglou-Athanassiou
    • 7
  • Georgios Trovas
    • 8
  1. 1.Physical Medicine & Rehabilitation DepartmentEuropean Interbalkan Medical CenterThessalonikiGreece
  2. 2.Medical School of PatrasRio, PatrasGreece
  3. 3.Medical School of ThessalyLarissaGreece
  4. 4.Department of Medical LaboratoriesTechnological Educational Institute of AthensAthensGreece
  5. 5.Department of Kinesitherapy, Faculty of Public HealthMedical University of SofiaSofiaBulgaria
  6. 6.2nd Orthopaedic DepartmentAthens University; Konstantopoulio General HospitalAthensGreece
  7. 7.Endocrinology DepartmentGeneral Hospital Asklepieio VoulasVoulaGreece
  8. 8.Laboratory for Research of the Musculoskeletal SystemUniversity of AthensKifissiaGreece

Personalised recommendations